Literature DB >> 30472046

Donor limb assessment after vascularized groin lymph node transfer for the treatment of breast cancer-related lymphedema: Clinical and lymphoscintigraphy findings.

Hin-Lun Liu1, Suet-Ying Pang2, Chung-Ching Lee2.   

Abstract

INTRODUCTION: Vascularized lymph node transfer is an established treatment for secondary lymphedema. Different donor sites of lymph node flap have been described. In our institute, vascularized groin lymph node (VGLN) flap is the workhorse flap for treating breast cancer-related lymphedema (BCRL). Potential complications of VGLN flap harvesting include seroma formation, thigh dysaesthesia, and iatrogenic lymphedema.
METHODS: Between August 2013 and June 2016, 30 consecutive patients with a mean age of 60 years underwent VGLN transfer for BCRL. Reverse mapping of lower limb lymphatics with patent blue solution was performed in all cases. The donor limb conditions were assessed clinically with limb circumference measurement and radiologically with lymphoscintigraphy. Postoperative lymphoscintigraphy findings and transport indexes were compared between the donor and nonoperated limbs.
RESULTS: The mean follow-up period was 22.11 ± 7.83 months. Three (10%) patients developed groin seroma and 18 (60%) patients complained of transient thigh dysaesthesia. There was no clinically detectable donor limb lymphedema. Lymphoscintigraphy was performed at a mean of 13 months after operation. The mean transport indexes of the nonoperated limbs and donor limbs were 2.04 and 3.32, respectively. For the donor limbs, all patients had normal distribution pattern of contrast uptake. No dermal backflow pattern was demonstrated.
CONCLUSION: With good knowledge of groin anatomy and meticulous surgical skills, VGLN flap can be harvested without causing major consequence to the donor limb.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Breast cancer-related lymphedema; Groin lymph node flap; Lymphoscintigraphy; Reverse mapping; Transport index; Vascularized lymph node transfer

Mesh:

Year:  2018        PMID: 30472046     DOI: 10.1016/j.bjps.2018.10.013

Source DB:  PubMed          Journal:  J Plast Reconstr Aesthet Surg        ISSN: 1748-6815            Impact factor:   2.740


  6 in total

Review 1.  Combined deep inferior epigastric artery perforator flap with vascularized groin lymph node transplant for treatment of breast cancer-related lymphedema.

Authors:  Mark V Schaverien; Edward I Chang
Journal:  Gland Surg       Date:  2021-01

2.  Lessons Learnt from an 11-year Experience with Lymphatic Surgery and a Systematic Review of Reported Complications: Technical Considerations to Reduce Morbidity.

Authors:  Pedro Ciudad; Joseph M Escandón; Oscar J Manrique; Valeria P Bustos
Journal:  Arch Plast Surg       Date:  2022-04-06

Review 3.  IGCS Intraoperative Technology Taskforce. Update on near infrared imaging technology: beyond white light and the naked eye, indocyanine green and near infrared technology in the treatment of gynecologic cancers.

Authors:  Nadeem R Abu-Rustum; Roberto Angioli; Arthur E Bailey; Vance Broach; Alessandro Buda; Michelle R Coriddi; Joseph H Dayan; Michael Frumovitz; Yong Man Kim; Rainer Kimmig; Mario M Leitao; Mustafa Zelal Muallem; Matt McKittrick; Babak Mehrara; Roberto Montera; Lea A Moukarzel; Raj Naik; Silvana Pedra Nobre; Marie Plante; Francesco Plotti; Oliver Zivanovic
Journal:  Int J Gynecol Cancer       Date:  2020-03-30       Impact factor: 3.437

4.  Controversies in Surgical Management of Lymphedema.

Authors:  Summer E Hanson; Edward I Chang; Mark V Schaverien; Carrie Chu; Jesse C Selber; Matthew M Hanasono
Journal:  Plast Reconstr Surg Glob Open       Date:  2020-03-27

Review 5.  Lymphedema in survivors of breast cancer.

Authors:  Lin He; Huili Qu; Qian Wu; Yuhua Song
Journal:  Oncol Lett       Date:  2020-01-16       Impact factor: 2.967

Review 6.  Lymphoscintigraphy for Evaluation of Lymphedema Treatment: A Systematic Review.

Authors:  Antonio J Forte; Daniel Boczar; Maria T Huayllani; Xiaona Lu; Pedro Ciudad
Journal:  Cureus       Date:  2019-12-12
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.